Investigates gut microbiota's role in disease-modifying therapy for multiple sclerosis, suggesting implications for treatment strategies.
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system influenced by genetic and environmental factors. The gut microbiota has emerged as a key environmental component potentially playing a role in MS development, immune dysregulation and disease progression.
No takes yet. Share an insight, caveat, or question.
Potapova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: